In a quiet corner of the biotech world, Genetoo is weaponizing surface physics to stop bacteria before they can attack. Armed with NASA-patented technology, this lean startup is tackling one of healthcare's most expensive nightmares: biofilm infections on medical implants.

"They're not fighting bacteria with chemistry—they're making the surface so hostile that bacteria simply can't land."

What makes Genetoo genuinely unique is their physical approach to a biological problem. Most competitors (like Covalon or BioCoat) use chemical coatings or antimicrobial agents that can leach out or trigger resistance. Genetoo's method is permanent, non-leaching, and works by physics alone. It's the difference between a non-stick pan that wears out versus one molecularly engineered to never stick.

• NASA-patented surface energy modification (not chemical coatings)
• Permanent, non-leaching solution that can't trigger resistance
• Targeting $100B+ medical implant infection market
• Tiny team with $0.8M suggests early commercial traction
• Strong IP moat from space technology transfer